Medical education on cannabis and cannabinoids: Perspectives, challenges, and opportunities

M A Ware; D Ziemianski

doi:10.1002/cpt.103

Medical education on cannabis and cannabinoids: Perspectives, challenges, and opportunities

Clin Pharmacol Ther. 2015 Jun;97(6):548-50. doi: 10.1002/cpt.103.

Authors

M A Ware^{1

2}, D Ziemianski²

Affiliations

¹ Departments of Anesthesia and Family Medicine, McGill University, Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec, Canada.
² Canadian Consortium for the Investigation of Cannabinoids, Montreal, Quebec, Canada.

PMID: 25728558
DOI: 10.1002/cpt.103

Abstract

The global regulatory landscape regarding the medical use of cannabis and cannabinoids is changing rapidly. This has considerable impact on health care professionals who currently receive little or no education on issues regarding medical cannabis. We propose a 'cannabis curriculum' that covers the spectrum of historical, botanical, physiological, clinical and legal issues to allow health care professionals to engage in meaningful discussions with their patients and colleagues around this stigmatized and controversial subject.

MeSH terms

Cannabinoids / therapeutic use*
Curriculum
Education, Medical*
Humans
Medical Marijuana / therapeutic use*
Phytotherapy*

Substances

Cannabinoids
Medical Marijuana